Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
65 studies found for:    Open Studies | "Vitamin K"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Vitamin K" (65 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Vitamin K1 to Slow Progression of Vascular Calcification in HD Patients
Condition: Cardiovascular Diseases
Intervention: Drug: Vitamin K1
2 Recruiting Vitamin K Supplementation in Patients on Hemodialysis
Conditions: End Stage Renal Failure on Dialysis;   Atrial Fibrillation
Intervention: Drug: vitamin K1
3 Recruiting Vitamin K and Glucose Metabolism in Children at Risk for Diabetes (Vita-K 'n' Kids Study)
Conditions: Obesity;   Insulin Resistance;   Insulin Sensitivity;   Prediabetes;   Dyslipidemia;   Diabetes
Interventions: Dietary Supplement: Placebo-Control;   Dietary Supplement: Low-Dose Vitamin K2 (menaquinone-7; 45 mcg/d);   Dietary Supplement: High-Dose Vitamin K2 (menaquinone-7; 90 mcg/d)
4 Recruiting Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K 'n' Kids Study II)
Conditions: Obesity;   Insulin Resistance;   Obesity in Diabetes;   Nutritional and Metabolic Diseases;   Hyperlipidemia;   Hyperglycemia;   Cardiovascular Diseases
Interventions: Dietary Supplement: Placebo-Control;   Dietary Supplement: Low-Dose Vitamin K2 (menaquinone-7; 45-mcg/d);   Dietary Supplement: High-Dose Vitamin K2 (menaquinone-7; 90 mcg/d)
5 Recruiting Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy
Conditions: Calciphylaxis;   Calcific Uremic Arteriolopathy
Interventions: Dietary Supplement: Vitamin K;   Other: Placebo
6 Recruiting Vitamin K to Attenuate Coronary Artery Calcification in Hemodialysis Patients
Condition: Endstage Kidney Disease
Interventions: Drug: Vitamin K1;   Drug: Chrystalline Lactose
7 Recruiting Bicuspid Aortic Valve Stenosis and the Effect of vItamin K2 on Calciummetabolism on 18F-NaF PET/MRI
Conditions: Aortic Valve Stenosis;   Bicuspid Aortic Valve
Interventions: Dietary Supplement: Vitamin K2;   Other: Placebo
8 Recruiting Vitamin K and Glucose Metabolism in Adults at Risk for Diabetes (Vita-K 'n' Adults Study)
Conditions: Obesity;   Insulin Resistance;   Insulin Sensitivity;   Beta-Cell Dysfunction;   Prediabetes
Interventions: Dietary Supplement: Placebo;   Dietary Supplement: Low-Dose Vitamin K2 Supplement (menaquinone-7; 90-mcg/d);   Dietary Supplement: High-Dose Vitamin K2 Supplement (menaquinone-7; 180-mcg/d)
9 Recruiting Vitamin K2 for Reduction the Calcium at Carotid Bifurcation in Patients With Subcritical Lesions
Condition: Carotid Plaques
Intervention: Other: Nutraceutical product based on vitamin K2 (PLAK2)
10 Recruiting Treatment to Reduce Vascular Calcification In Hemodialysis Patients Using Vitamin K
Conditions: Vascular Calcification;   Systemic and Arterial Stiffness;   Complication of Hemodialysis;   Deficiency of Vitamin K2
Intervention: Drug: menaquinone-7
11 Recruiting Effect on Vascular Calcification of Replacing Warfarin by Rivaroxaban With or Without VitK2 in Hemodialysis Patients
Condition: Vascular Calcification
Interventions: Drug: rivaroxaban;   Dietary Supplement: Vitamin K2
12 Recruiting Effect of Vitamin K2 (MK7) on Cardiovascular and Bone Disease in Dialysis Patients
Conditions: Vitamin K Supplementation;   Endstage Renal Disease;   Cardiovascular Disease;   Bone Disease
Interventions: Dietary Supplement: Vitamin K2 (MK7);   Other: Placebo
13 Not yet recruiting INVestIgation of rheumatiC AF Treatment Using Vitamin K Antagonists, Rivaroxaban or Aspirin Studies, Non-Inferiority
Condition: Rheumatic Heart Disease
Interventions: Drug: Rivaroxaban (20 mg);   Drug: Vitamin K antagonists (VKA)
14 Not yet recruiting Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over
Condition: Atrial Fibrillation
Interventions: Drug: Direct oral antocoagulant: dabigatran, rivaroxaban, apixaban;   Drug: Vitamin K antagonist: warfarin, fluindione, acenocoumarol
15 Recruiting Apixaban During Atrial Fibrillation Catheter Ablation: Comparison to Vitamin K Antagonist Therapy
Condition: Atrial Fibrillation
Interventions: Drug: Vitamin K antagonist;   Drug: Apixaban
16 Recruiting Patient Convenience Study- NIS RELATE
Condition: Atrial Fibrillation
Interventions: Drug: Pradaxa (dabigatran);   Drug: Vitamin K antagonist
17 Recruiting A Randomized, Placebo-controlled, Double Blind Trial to Investigate Whether Vitamin K2 Can Influence Arterial Calcification in Patients With Type 2 Diabetes
Conditions: Arterial Calcification;   Diabetes Mellitus Type 2
Interventions: Dietary Supplement: Menaquinone-7;   Dietary Supplement: Placebo
18 Not yet recruiting Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Condition: Atrial Fibrillation
Interventions: Drug: Edoxaban;   Drug: Clopidogrel;   Drug: Prasugrel;   Drug: ticagrelor
19 Not yet recruiting A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation
Condition: Thrombosis
Interventions: Drug: Apixaban;   Drug: Vitamin K Antagonist (VKA);   Drug: Low Molecular Weight Heparin (LMWH)
20 Recruiting Sorafenib Plus Vitamin K1 Versus Sorafenib in Advanced Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Sorafenib 400mg twice daily + intravenous infusion ofVit K1;   Drug: Sorafenib 400 mg twice daily + Intravenousinfusion of placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.